IOL Chemicals and Pharmaceuticals Share Price
NiveshIQ
NSE: TORNTPHARM · Healthcare
Torrent Pharmaceuticals Ltd.
₹4,595.00▼ ₹18.40 (-0.40%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on TORNTPHARM. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Limited is a leading Indian pharma company that designs, develops, manufactures, markets, and distributes branded and generic formulations across India and internationally, including the US, Brazil, Germany, and Malta. The company’s revenue of ₹17,442 crore in FY27 was driven by strong sales in anti-diabetic, anti-microbial, cardiovascular, CNS, and oncology segments, with a 51% YoY rise in Q2 FY27. Net profit for Q2 FY27 fell 10% to ₹534 crore, reflecting higher cost of goods sold and marketing expenses. Torrent also generates revenue from contract manufacturing services, leveraging its advanced manufacturing facilities. The firm maintains a competitive edge through a diversified product portfolio under brands such as Tedibar, Shelcal, and ProZuca, and a robust R&D
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹10,728 Cr +11.52% | ₹11,516 Cr +7.35% | ₹13,980 Cr +21.40% |
| EBITDA Margin | 31.39% | 32.31% | 32.61% |
| Net Profit | ₹1,656 Cr +33.01% | ₹1,911 Cr +15.40% | ₹2,163 Cr +13.19% |
| EPS | ₹48.94 | ₹56.47 | ₹63.92 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
TORNTPHARM Share Price Today - Torrent Pharmaceuticals on NSE/BSE
Lincoln Pharmaceuticals (LINCOLN): Lincoln Pharma Share Price Falls 8.76% Today to Rs 508.70
🔒
+ 3 more stories about Torrent Pharmaceuticals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹4, 979 Cr, PAT ₹534 Cr, EPS ₹14.05, EBITDA margin 33.5%. Growth context: revenue YoY +50.8%, PAT YoY -9.6%, revenue QoQ +1.2%, PAT QoQ -5.7%.
Management highlights product launches, approvals, therapy‑mix improvement, order wins, deal pipeline, and backlog build...
FY26 (last completed FY): revenue ₹13, 980 Cr, PAT ₹2, 163 Cr, EBITDA margin 32.6%, EPS ₹63.92. Year-on-year: revenue Yo...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.Supriya Lifescience Ltd.Suven Life Sciences Ltd.Syngene International Ltd.Thyrocare Technologies Ltd.Ventive Hospitality Ltd.Vijaya Diagnostic Centre Ltd.Viyash Scientific Ltd.Wockhardt Ltd.Yatharth Hospital & Trauma Care Services Ltd.Zydus Lifesciences Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for TORNTPHARM
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track TORNTPHARM alongside your other holdings
Unlock full TORNTPHARM research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Torrent Pharmaceuticals Ltd.?
NiveshIQ detects active intelligence signals for Torrent Pharmaceuticals Ltd. (TORNTPHARM) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Torrent Pharmaceuticals Ltd.?
Torrent Pharmaceuticals Ltd. operates in the Healthcare sector with a market capitalisation of ₹17,209,363.0L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.